VKH
CBAY

Virtu KCG Holdings’s Cymabay Therapeutics CBAY Stock Holding History

Virtu KCG Holdings’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-17,208
Closed -$33K – 3892
2016
Q3 		$33K Buy
+17,208
New +$34.2K ﹤0.01% 2858
2016
Q1 		– Sell
-18,946
Closed -$32K – 3829
2015
Q4 		$32K Sell
18,946
-3,694
-16% -$6.02K ﹤0.01% 3239
2015
Q3 		$44K Buy
+22,640
New +$61.6K ﹤0.01% 3019

Other funds holding CBAY

A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
KCM
Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $186M AUM 35.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JGC
J. Goldman & Co New York $2.16B AUM 33.8% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return